Complex Regional Pain Syndrome (CRPS) Market Size, Share, Epidemiology, Market Research and Forecast Report 2030 by Delv

1. DelveInsight’s ‘Complex Regional Pain Syndrome (CRPS) Market Insights, Epidemiology and Market Forecast 2030’ report delivers an in-depth understanding of the CRPS, historical and forecasted epidemiology as well as the CRPS market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan. Complex Regional Pain Syndrome Disease Overview Complex Regional Pain Syndrome (CRPS) is one of the most challenging chronic pain condition that is characterized by progressively worsening spontaneous regional pain without dermatomal distribution. The pain experienced is out of proportion in time and severity to the inciting event and accompanied by symptoms that vary in severity including skin changes, autonomic dysfunction, abnormal sensory and motor changes, and trophic changes. CRPS may develop after major trauma, surgery, or minor injury, and progresses with a variable course that ranges from self-limiting, mild symptomatology to chronic disease. In many cases, disease progression is debilitating and severely limits patients’ quality of life, creating a tremendous burden on patients and their families. Over time, CRPS has been defined and redefined. CRPS develops after an inciting noxious stimulus to an affected limb. There is little agreement with regards to the etiology, symptoms, clinical presentation, diagnosis, or treatment of CRPS. Request for a detailed sample https://www.delveinsight.com/sample-request/complex-regional-pain- syndrome-market Complex Regional Pain Syndrome Disease Diagnosis copy of the report:

2. There are no objective diagnostic tests for CRPS. Since, its pathophysiologic basis of CRPS is not fully understood, mechanism-based diagnosis is not yet feasible. Therefore, the diagnosis of CRPS is based solely on clinical signs and symptoms. The actual diagnosis of CRPS is made solely based on history and physical examination to determine whether a patient meets CRPS diagnostic criteria (often called the Budapest criteria). Other than this, objective testing (thermography, triple- phase bone scan, quantitative sudomotor axon reflex test, or a trial sympathetic ganglion block) may be used to support a clinical diagnosis. Complex Regional Pain Syndrome Disease Treatment Current treatment for Complex Regional Pain Syndrome includes: 1. Non-surgical methods like medications (Pain reliever, Antidepressants and anticonvulsants, Corticosteroids, and Sympathetic nerve-blocking medication) 2. Biofeedback 3. Therapy. Complex Regional Pain Syndrome Disease Epidemiology Insights The Complex Regional Pain Syndrome epidemiology division provides the insights about historical and current CRPS patient pool and forecasted trend for each seven major countries. Key Findings  In the year 2017, the total prevalent case of CRPS was 310,489 in the 7MM which are expected to grow during the study period, i.e., 2017–2030. Click here and download our sample pages. Country Wise- CRPS Epidemiology • In the United States, the total number of prevalent cases of CRPS was 219,317 cases in the year 2017 which are expected to grow during the study period, i.e., 2017– 2030. • In the year 2017, the total prevalent cases of CRPS were 84,850 cases in EU-5 which are expected to grow during the study period, i.e., 2017–2030. • In Japan, the total number of prevalent cases of CRPS was 6,323 cases in the year 2017 which are expected to grow during the study period, i.e., 2017–2030. Get more useful insights from our report: https://www.delveinsight.com/report- store/complex-regional-pain-syndrome-epidemiology-forecast

3. Complex Regional Pain Syndrome Disease Emerging Drugs  TAK-935/OV935 by Ovid Therapeutics/Takeda  BHV-5000 by AstraZeneca/Biohaven Pharmaceutical Complex Regional Pain Syndrome Disease Market Outlook The Complex Regional Pain Syndrome market size in the 7MM is expected to change during the study period 2017–2030. The therapeutic market of CRPS in the seven major markets was USD 65 million in 2017 which is expected to increase during study period (2017–2030). According to the estimates, the highest market size of CRPS is found in the United States followed by Germany, France, and the UK. CLICK HERE AND VISIT OUR REPOSITORY OF REPORTS.